3D Medicines, Inc. (HK:1244) has released an update.
3D Medicines Inc. has announced its upcoming annual general meeting scheduled for June 28, 2024, where they will address key corporate matters including the adoption of the audited financial statements for 2023, re-election of directors, and appointment of a new auditor. Shareholders will consider resolutions pertaining to director remuneration and the authorization for the board to issue additional shares or convertible securities.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.
